Acid ceramidase inhibition enhances venetoclax sensitivity in preclinical models of acute myeloid leukemia

被引：0
|
作者：
Ung, Johnson
Tan, Su-Fern
Shaw, Jeremy J.
Fox, Todd E.
Taori, Maansi
Claxton, David F.
Fisher-Wellman, Kelsey H.
Cabot, Myles C.
Feith, David J.
Loughran, Thomas P.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4740
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4740
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Venetoclax in adult acute myeloid leukemia
    Hu, Mengci
    Li, Wenzhe
    Zhang, Youshan
    Liang, Caixia
    Tan, Jie
    Wang, Ya
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [22] The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia
    Li, Xinyu
    Su, Yongwei
    Hege, Katie
    Madlambayan, Gerard
    Edwards, Holly
    Knight, Tristan
    Polin, Lisa
    Kushner, Juiwanna
    Dzinic, Sijana H.
    White, Kathryn
    Yang, Jay
    Miller, Regan
    Wang, Guan
    Zhao, Lijing
    Wang, Yue
    Lin, Hai
    Taub, Jeffrey W.
    Ge, Yubin
    HAEMATOLOGICA, 2021, 106 (05) : 1262 - 1277
  • [23] Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia
    Wang, Xiangmeng
    Mak, Po Yee
    Mu, Hong
    Tao, Wenjing
    Rao, Arvind
    Visweswaran, Ravikumar
    Ruvolo, Vivian
    Pachter, Jonathan A.
    Weaver, David T.
    Andreeff, Michael
    Xu, Bing
    Carter, Bing Z.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (08) : 1636 - 1648
  • [24] Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway
    Yu, Xibao
    Wang, Yan
    Tan, Jiaxiong
    Li, Yuchen
    Yang, Pengyue
    Liu, Xuan
    Lai, Jing
    Zhang, Yue
    Cai, Letong
    Gu, Yinfeng
    Xu, Ling
    Li, Yangqiu
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [25] Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway
    Xibao Yu
    Yan Wang
    Jiaxiong Tan
    Yuchen Li
    Pengyue Yang
    Xuan Liu
    Jing Lai
    Yue Zhang
    Letong Cai
    Yinfeng Gu
    Ling Xu
    Yangqiu Li
    Cell Death Discovery, 10
  • [26] Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
    Griffioen, Mila S.
    de Leeuw, David C.
    Janssen, Jeroen J. W. M.
    Smit, Linda
    CANCERS, 2022, 14 (14)
  • [27] Targeting PLZF Enhances Glucocorticoid Sensitivity in Acute Myeloid Leukemia
    Hajmirza, Azadeh
    Simon, Laura
    Chagraoui, Jalila
    Mayotte, Nadine
    Spinella, Jean-Francois
    Macrae, Tara
    Lehnertz, Bernhard
    Bertomeu, Thierry
    Coulombe-Huntington, Jasmin
    Boucher, Genevieve
    Lemieux, Sebastien
    Tyers, Mike
    Hebert, Josee
    Sauvageau, Guy
    BLOOD, 2022, 140 : 8825 - 8826
  • [28] Superior Anti-Leukemic Effects of Combined Acid Ceramidase and Bcl-2 Inhibition in Acute Myeloid Leukemia
    Ung, Johnson
    Tan, Su-Fern
    Shaw, Jeremy
    Fox, Todd
    Kester, Mark
    Feith, David
    Loughran, Thomas, Jr.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S211 - S212
  • [29] Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia
    Khokhlatchev, Andrei, V
    Sharma, Arati
    Deering, Tye G.
    Shaw, Jeremy J. P.
    Costa-Pinheiro, Pedro
    Golla, Upendarrao
    Annageldiyev, Charyguly
    Cabot, Myles C.
    Conaway, Mark R.
    Tan, Su-Fern
    Ung, Johnson
    Feith, David J.
    Loughran, Thomas P., Jr.
    Claxton, David F.
    Fox, Todd E.
    Kester, Mark
    FASEB JOURNAL, 2022, 36 (10):
  • [30] Combined venetoclax and alvocidib in acute myeloid leukemia
    Bogenberger, James
    Whatcott, Clifford
    Hansen, Nanna
    Delman, Devora
    Shi, Chang-Xin
    Kim, Wontak
    Haws, Hillary
    Soh, Katherine
    Lee, Ye Sol
    Peterson, Peter
    Siddiqui-Jain, Adam
    Weitman, Steven
    Stewart, Keith
    Bearss, David
    Mesa, Ruben
    Warner, Steven
    Tibes, Raoul
    ONCOTARGET, 2017, 8 (63): : 107206 - 107222
12345